{{Rsnum
|rsid=3181366
|Gene=TNFSF8
|Chromosome=9
|position=114904496
|Orientation=minus
|GMAF=0.3347
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TNFSF8
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 41.4 | 44.1 | 14.4
| HCB | 47.0 | 48.5 | 4.5
| JPT | 45.5 | 47.7 | 6.8
| YRI | 61.3 | 33.8 | 4.9
| ASW | 43.6 | 49.1 | 7.3
| CHB | 47.0 | 48.5 | 4.5
| CHD | 50.5 | 42.1 | 7.5
| GIH | 37.6 | 46.5 | 15.8
| LWK | 56.5 | 42.6 | 0.9
| MEX | 24.1 | 55.2 | 20.7
| MKK | 49.3 | 42.0 | 8.7
| TSI | 27.7 | 60.4 | 11.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21292647
|Title=Association of a novel functional promoter variant (rs2075533 C&gt;T) in the apoptosis gene TNFSF8 with risk of lung cancer - a finding from Texas lung cancer genome-wide association study
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}